DuPont de Nemours Inc., established in 1802, is a science-based leader in advanced materials and specialty chemicals, serving sectors such as automotive, electronics, and healthcare with products like Kevlar®, Tyvek®, and Corian®. Generating annual revenues exceeding $20 billion, it leverages strong R&D investments and a robust patent portfolio to sustain high profit margins. Under the leadership of CEO Edward Breen since 2015, the company maintains a top-ten position in the global chemicals market. DuPont is actively investing in sustainable materials and digital initiatives to drive future growth while navigating industry challenges.
Financial Statements
In thousands, USD
FY 2025
FY 2024
FY 2023
FY 2022
Total Revenues
6,849,000
6,719,000
6,614,000
13,017,000
Cost of Sales
4,486,000
4,499,000
4,442,000
8,402,000
Gross Profit
2,363,000
2,220,000
2,172,000
4,615,000
Selling, General & Administrative Expenses
1,019,000
976,000
891,000
1,467,000
Depreciation & Amortization Expenses
291,000
294,000
267,000
590,000
Research & Development Expenses
193,000
203,000
192,000
536,000
Other Operating Expenses
354,000
147,000
786,000
348,000
Operating Profit
506,000
600,000
36,000
1,674,000
Interest and Investment Income
(7,000)
(6,000)
1,000
75,000
Interest Expense
(313,000)
(366,000)
(396,000)
(492,000)
Non-Operating Income
14,000
(111,000)
80,000
191,000
Total Non-Operating Income
(306,000)
(483,000)
(315,000)
(226,000)
Income Before Provision for Income Taxes
200,000
117,000
(279,000)
1,448,000
Provision for Income Taxes
102,000
213,000
(217,000)
387,000
Consolidated Net Income
98,000
(96,000)
(62,000)
1,061,000
Net Income Attributable to Minority Interests and Other
41,000
35,000
39,000
49,000
Net Income Attributable to Discontinued Operations
(836,000)
834,000
524,000
4,856,000
Net Income Attributable to Common Shareholders
(779,000)
703,000
423,000
5,868,000
Basic EPS
-1.87
1.68
0.94
2.02
Diluted EPS
-1.86
1.68
0.94
2.02
Basic Weighted Average Shares Outstanding
417,500
419,200
449,900
498,500
Diluted Weighted Average Shares Outstanding
419,200
419,200
449,900
499,400
Shares Outstanding
409,195
417,994
430,110
458,124
FY 2025
FY 2024
FY 2023
FY 2022
Cash and Cash Equivalents
715,000
1,792,000
2,392,000
3,662,000
Short-Term Investments
—
—
—
1,302,000
Total Cash and Cash Equivalents
715,000
1,792,000
2,392,000
4,964,000
Accounts Receivable
1,669,000
1,342,000
2,370,000
2,518,000
Total Trade Receivables
1,669,000
1,342,000
2,370,000
2,518,000
Inventories
1,172,000
1,130,000
2,147,000
2,329,000
Other Current Assets
2,019,000
16,511,000
605,000
1,459,000
Total Current Assets
5,575,000
20,775,000
7,514,000
11,270,000
Net Property, Plant & Equipment
3,464,000
3,454,000
5,884,000
5,731,000
Net Intangible Assets
2,936,000
3,178,000
5,814,000
5,495,000
Goodwill
7,915,000
7,561,000
16,720,000
16,663,000
Long-Term Investments
432,000
418,000
1,071,000
733,000
Other Long-Term Assets
13,789,000
13,657,000
26,703,000
25,817,000
Total Assets
21,575,000
36,636,000
38,552,000
41,355,000
Accounts Payable
995,000
1,054,000
1,675,000
2,103,000
Accrued Expenses
882,000
784,000
1,269,000
951,000
Short-Term Debt
60,000
1,848,000
—
300,000
Other Current Liabilities
368,000
1,810,000
154,000
379,000
Total Current Liabilities
2,305,000
5,496,000
3,098,000
3,733,000
Long-Term Debt
3,134,000
5,323,000
7,800,000
7,774,000
Other Long-Term Liabilities
4,066,000
4,048,000
5,858,000
5,662,000
Total Long-Term Liabilities
7,200,000
9,371,000
13,658,000
13,436,000
Total Liabilities
7,472,000
12,843,000
13,827,000
14,338,000
Common Stock
4,000
4,000
4,000
5,000
Additional Paid-in Capital
38,718,000
47,922,000
48,059,000
48,420,000
Accumulated Other Comprehensive Income
(525,000)
(1,500,000)
(910,000)
(791,000)
Retained Earnings
(24,278,000)
(23,076,000)
(22,874,000)
(21,065,000)
Total Common Shareholders' Equity
13,919,000
23,350,000
24,279,000
26,569,000
Minority Interests and Other
184,000
443,000
446,000
448,000
Total Shareholders' Equity
14,103,000
23,793,000
24,725,000
27,017,000
Total Liabilities and Shareholders' Equity
21,575,000
36,636,000
38,552,000
41,355,000
FY 2025
FY 2024
FY 2023
FY 2022
Net Income
98,000
(96,000)
(62,000)
1,061,000
Depreciation & Amortization
647,000
635,000
580,000
1,135,000
Share-Based Compensation Expense
38,000
56,000
57,000
75,000
Other Adjustments
90,000
111,000
477,000
(167,000)
Changes in Trade Receivables
(201,000)
(83,000)
163,000
(79,000)
Changes in Inventories
(10,000)
61,000
117,000
(215,000)
Changes in Accounts Payable
61,000
(36,000)
(232,000)
(138,000)
Changes in Other Operating Activities
689,000
1,199,000
818,000
(1,084,000)
Cash from Operating Activities
1,412,000
1,847,000
1,918,000
588,000
Capital Expenditure
(333,000)
(285,000)
(302,000)
(662,000)
Proceeds from Sale of Property, Plant & Equipment
—
(7,000)
1,236,000
10,951,000
Purchases of Investments
—
—
(32,000)
(1,317,000)
Proceeds from Sale of Investments
—
—
1,334,000
15,000
Payments for Business Acquisitions
(55,000)
(313,000)
(1,761,000)
5,000
Other Investing Activities
(299,000)
(244,000)
(336,000)
(69,000)
Cash from Investing Activities
(687,000)
(849,000)
139,000
8,923,000
Issuance of Short-Term Debt
60,000
—
—
(150,000)
Net Issuance / (Repayments) of Short-Term Debt
60,000
—
—
(150,000)
Issuance of Long-Term Debt
—
—
—
600,000
Repayments of Long-Term Debt
(4,134,000)
(687,000)
(300,000)
(3,100,000)
Net Issuance / (Repayments) of Long-Term Debt
(4,134,000)
(687,000)
(300,000)
(2,500,000)
Issuance of Common Shares
32,000
50,000
27,000
88,000
Repurchases of Common Shares
(500,000)
(500,000)
(2,000,000)
(4,375,000)
Net Issuance / (Repurchases) of Common Shares
(468,000)
(450,000)
(1,973,000)
(4,287,000)
Common Share Dividends Paid
(597,000)
(635,000)
(651,000)
(652,000)
Other Financing Activities
3,271,000
(75,000)
(65,000)
(78,000)
Cash from Financing Activities
(1,868,000)
(1,847,000)
(2,989,000)
(7,667,000)
Effect of Exchange Rate Changes on Cash and Cash Equivalents
11,000
(62,000)
(36,000)
(148,000)
Increase / (Decrease) in Cash, Cash Equivalents and Restricted Cash